NIAID Funding Opportunities: Rapid Investigation of SARS-CoV-2 and COVID-19

Funding Opportunities

• PAR-20-177, Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21, Clinical Trial Not Allowed)
• PAR-20-178, Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01, Clinical Trial Not Allowed)

For more, see NIAID Opportunities & Announcements. 

You can follow us on Twitter: @NIAIDFunding.